Impact of safety warnings on antipsychotic prescriptions in dementia: nothing has changed but the years and the substances.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Neuropsychopharmacology

• Publication date

  2013-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.euroneuro.2013.02.001PMID 23498307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in trend of antipsychotics prescription in patients treated with cholinesterase inhibitors after warnings from Italian Medicines Agency. Results from the EPIFARM-Elderly Project.

  2012influential reference
• Psychosocial interventions for reducing antipsychotic medication in care home residents.

  2012cited by this paper
• Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms.

  2012cited by this paper
• Behavioral and Psychological Symptoms of Dementia

  2012cited by this paper
• Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study

  2012cited by this paper
• Impact of FDA Drug Risk Communications on Health Care Utilization and Health Behaviors: A Systematic Review

  2012cited by this paper
• [Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor].

  2012cited by this paper
• [Behavioral and psychological symptoms of dementia].

  2011cited by this paper
• Diabetes prevalence based on health insurance claims: large differences between companies

  2011cited by this paper
• Duale Plättchenaggregationshemmung bei Koronarstents: Zwei Stellungnahmen im Diskussionsforum der Arzneimittelkommission der deutschen Ärzteschaft (Arzneiverordnung in der Praxis, September 2008) - Online ZFA

  2011cited by this paper
• Psychotropic Medication Burden and Factors Associated with Antipsychotic Use: An Analysis of a Population‐Based Sample of Community‐Dwelling Older Persons with Dementia

  2011cited by this paper
• Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland

  2011cited by this paper
• Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia

  2011cited by this paper
• Trends in antipsychotic use in dementia 1999-2007.

  2011cited by this paper
• Utilization Patterns of Ambulatory Medical Care before and after the Diagnosis of Dementia in Germany – Results of a Case-Control Study

  2010cited by this paper
• The pharmacotherapy of neuropsychiatric symptoms of dementia: a cross-sectional study in 18 homes for the elderly in Berlin.

  2010cited by this paper
• Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment

  2010cited by this paper
• The burden of psychotropic drug prescribingin people with dementia: a populationdatabase study.

  2010cited by this paper
• Impact of FDA black box advisory on antipsychotic medication use.

  2010cited by this paper
• Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany

  2010cited by this paper
• A review of the evidence

  2009cited by this paper
• The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.

  2009cited by this paper
• Risiken von Antipsychotika im Alter, speziell bei Demenzen 1Prof. Dr. Hans Gutzmann zum 60. Geburtstag gewidmet.

  2009cited by this paper
• Neuropsychiatric symptoms in dementia: Importance and treatment considerations

  2008cited by this paper
• Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis

  2008cited by this paper
• Neuroleptic drugs in dementia: benefits and harm

  2006cited by this paper
• Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.

  2006cited by this paper
• Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

  2006cited by this paper
• Outcomes of antipsychotic drug use in community-dwelling elders with dementia.

  2006cited by this paper
• Atypical antipsychotics for aggression and psychosis in Alzheimer's disease

  2006cited by this paper
• Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

  2006cited by this paper
• Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

  2005cited by this paper
• Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.

  2005cited by this paper
• Pharmacological treatment of neuropsychiatric symptoms of dementia.

  2005cited by this paper
• Are cognitively impaired individuals adequately represented in community surveys? Recruitment challenges and strategies to facilitate participation in community surveys of older adults. A review

  2004cited by this paper
• The incidence of mental and behavioral disturbances in dementia: the cache county study.

  2003cited by this paper
• The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

  2002cited by this paper
• Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging.

  2000cited by this paper
• Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment

  1997cited by this paper
• ALZHEIMER'S DISEASE INTERNATIONAL

  1997cited by this paper
• Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

  1990cited by this paper

• Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review

  2025cites this paper
• Drug-drug interactions in nursing home residents: analysis from the COME-ON trial.

  2023cites this paper
• Impact of Function-Focused Care on Psychotropic Medications and Opioid Use Among Assisted Living Residents.

  2022cites this paper
• Rapport 22-02. Après la crise COVID, quelles solutions pour l’EHPAD de demain ?

  2022cites this paper
• Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia

  2021influential citation
• Epidemiology of urticaria in German children

  2021cites this paper
• Epidemiologie der Urtikaria bei Kindern in Deutschland

  2021cites this paper
• Anticholinergic drug use and risk of mortality for people with dementia in Northern Ireland

  2020cites this paper
• Incidence, prevalence and prescription patterns of antipsychotic medications use in Asia and US: A cross-nation comparison with common data model.

  2020cites this paper
• Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy

  2019cites this paper
• Fourteen-Year Trends in the Use of Psychotropic Medications, Opioids, and Other Sedatives Among Institutionalized Older People in Helsinki, Finland.

  2019cites this paper
• Cost-effectiveness of atypical antipsychotics for the treatment of dementia in Thailand

  2019cites this paper
• Palliative medicine and end-of-life care.

  2019cites this paper
• Rationalising antipsychotic prescribing in dementia: a mixed-methods investigation

  2019cites this paper
• Antipsychotic use and related factors among people with dementia aged 75 years or older in Japan: A comprehensive population‐based estimation using medical and long‐term care data

  2018cites this paper
• Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in Germany

  2018influential citation
• The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?

  2018cites this paper
• ADMA and NT pro‐BNP are associated with overall mortality in elderly

  2018cites this paper
• Long-term use of antipsychotics in community-dwelling dementia patients: prevalence and profile accounting for unobservable time bias because of hospitalization

  2017cites this paper
• Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive Impairment.

  2017cites this paper
• Antipsychotic drug use in nursing home residents with and without dementia: keep an eye on the pro re nata medication

  2017cites this paper
• Trends and factors associated with antipsychotic use among elderly patients with dementia in Taiwan from 2005 to 2013: a population-based study

  2017cites this paper
• Antipsychotic Use in Dementia

  2017cites this paper
• International trends in antipsychotic use: A study in 16 countries, 2005-2014.

  2017cites this paper
• Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer’s disease in 2005-2011

  2017cites this paper
• Observation des pratiques d’évaluations des traitements par anticholinestérasiques et mémantine chez les patients atteints de maladies d'Alzheimer et apparentées dans les EHPAD en Sud-Landes

  2017cites this paper
• Incidence of Tube Feeding in 7174 Newly Admitted Nursing Home Residents With and Without Dementia

  2016cites this paper
• Antipsychotic use in dementia patients in a general practice setting: a Dutch population-based study

  2016influential citation
• Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013

  2016cites this paper
• The Role of Healthcare Databases in Pharmacovigilance of Psychotropic Drugs

  2016cites this paper
• The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study

  2016cites this paper
• Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer’s Disease

  2016cites this paper
• ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety

  2016cites this paper
• Persistence with antipsychotics in dementia patients in Germany
.

  2016cites this paper
• Psychotropic drug prescriptions in Western European nursing homes

  2016cites this paper
• A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia

  2016cites this paper
• Trends in the use and cost of antipsychotics among older adults from 2007 to 2013: a repeated cross-sectional study.

  2016cites this paper
• Geographical Variation in Antipsychotic Drug Use in Elderly Patients with Dementia: A Nationwide Study

  2016cites this paper
• [Different Regions, Differently Insured Populations? Socio-demographic and Health-related Differences Between Insurance Funds].

  2015cites this paper
• Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study

  2015cites this paper
• A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice

  2015cites this paper
• Pharmacotherapy of dementia in Germany: Results from a nationwide claims database.

  2015cites this paper
• Datenbanken 2009-2012

  2015cites this paper
• Comorbilidad médica y criterios de uso de antipsicóticos en ancianos

  2015cites this paper
• Efficacy and cost of atypical antipsychotics in treatment and management of dementia

  2015cites this paper
• Hyperkinetische Störungen im Kindes- und Jugendalter

  2015cites this paper
• Factors Related to Rejection of Care and Behaviors Directed towards Others: A Longitudinal Study in Nursing Home Residents with Dementia

  2015cites this paper
• University of Groningen A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice Zuidema,

  2015cites this paper
• Who gets dipyrone (metamizole) in Germany? Prescribing by age, sex and region

  2015cites this paper
• A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence

  2015cites this paper
• High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.

  2014cites this paper
• ADN‐1184 a monoaminergic ligand with 5‐HT6/7 receptor antagonist activity: pharmacological profile and potential therapeutic utility

  2014cites this paper
• Prevalence of dementia in nursing home and community-dwelling older adults in Germany

  2014cites this paper
• Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

  2014cites this paper
• Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

  2014cites this paper
• Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings.

  2014influential citation
• Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010

  2014influential citation
• Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia

  2014cites this paper
• Geschlechtsspezifische Inanspruchnahme bei der Arzneimittelversorgung in verschiedenen Lebensphasen

  2014cites this paper
• Atypical Antipsychotic-Induced Metabolic Disturbances in the Elderly

  2014cites this paper
• Steigende Verordnungszahlen von Protonenpumpenhemmern im ambulant-ärztlichen Bereich über die Jahre 2005 − 2013

  2014cites this paper
• Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.

  2014cites this paper
• ADN-1184 a monoaminergic ligand with 5-HT 6 / 7 receptor antagonism : pharmacological profile and potential therapeutic utility 1 Running Title : Pharmacology of the monoamine antagonist ADN-1184

  2013cites this paper
• Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study

  2013cites this paper
• Prescribing of psychotropic medications to the elderly population of a Canadian province: a retrospective study using administrative databases

  2013influential citation
• [Hyperkinetic disorders in childhood and adolescence- an analysis of KinderAGATE 2009-2012].

  2013cites this paper
• Gr up Sm

  year unknowncites this paper